DAYTON, Ohio--(BUSINESS WIRE)--Riverain Technologies announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for its Temporal Comparison software. This software electronically compares current and prior chest X-ray images and can help identify nodules that may be early-stage lung cancer, when there are more treatment options.
